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Background: An intensive glycemic control (IGC) with insulin in patients (pts) with acute coronary syndrome (ACS) reduces platelet reactivity 
during hospitalization compared to a conventional glycemic control (CGC). However, if an IGC has effects on platelet reactivity in pts with Acute 
Coronary Syndrome (ACS) after 12 months follow-up (FU) remains unexplored.
Methods: The CHIPS (Control de la HIperglucemia y Función Plaquetaria en Pacientes con Síndrome Coronario Agudo) study was a prospective, 
randomized trial evaluating the effects of IGC (glucose 80-120 mg/dL) compared to CGC (glucose ≤180mg/dL) on platelet reactivity in ACS pts 
presenting with hyperglycemia. Platelet aggregation was assessed by light transmittance aggregometry using ADP (5 and 20μM), collagen 6μg/ml, 
epinephrine 20μM and TRAP 25μS as platelet agonists after 12 months FU. Platelet activation was assessed using the platelet P2Y12 reactivity 
index (PRI) and surface expression of activated GPIIb/IIIa and P-selectin by flow cytometry after 12 months FU.
Results: Pts (n=104) were randomized to an IGC (n=53) or to a CGC (n=51). There were no differences between groups in baseline characteristics 
and platelet fuction. After 12 FU, we didn´t observe any differences in platelet reactivity in pts treated with IGC compared to CGC (Fig).
Conclusions: An intensive glycemic control wtih insulin in pts with ACS has not effect on platelet reactivity compared to a conventional glycemic 
control after 12 months FU.
